Schedule 13D ownership disclosure

Ocera Therapeutics, Inc.

Security class unavailable

Event date: 2017-02-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-035798
Form type
SC 13D/A
Filer
InterWest Partners IX, LP
CIK
CIK 1398928
Filed
Feb 09, 2017
Reporting period
Feb 07, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub